AC-OLE-01-VA Tolerability Study in Healthy Participants Under Different Dosing Conditions
NCT05628636
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer Disease
Interventions
DRUG:
AC-OLE-01-VA
Sponsor
Cerecin